Schaeffer's Top Stock Picks for '25

Biotech Stock Hits 3-Year Highs on Trial Results

Candel Therapeutics' cancer treatment met its goal in a late-stage trial

Deputy Editor
Dec 11, 2024 at 10:55 AM
facebook X logo linkedin


Candel Therapeutics Inc (NASDAQ:CADL) is soaring today, up 164% at $12.17 at last glance and earlier hitting a three-year high of $14.60, after the biotech company's prostate cancer immunotherapy treatment, CAN-2409, met its goal in a late-stage study. Combined with radiation therapy, it significantly improved the time patients lived without signs or symptoms of the cancer. 

On the charts, CADL inched above its mid-May peak to mark its highest levels since September 2021. And before today, the 320-day moving average provided close support this month. On the short sell restricted (SSR) list today amid the volatility, CADL is up 658% since the start of 2024. 

Candel Therapeutics stock's typically quiet options pits are bustling in response. So far, 3,393 calls and 4,969 puts have been exchanged, which is 8.7 times the average daily options volume already. The January 2025 15-strike call is the most popular, with new positions being bought to open there. 

Meanwhile, short interest is up 27.8% over the past month and accounts for 9.2% of the stock's available float. With these shorts now underwater, short covering will likely follow. 

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?